Search Results

A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension

Authors: Karlson, Bjorn Wilgot; Zetterstrand, Sofia; Olofsson, Bertil; Elmfeldt, Dag

Source: Blood Pressure, Volume 18, Number 3, June 2009 , pp. 149-156(8)

Publisher: Informa Healthcare

Efficacy of Low-Dose Hydrochlorothiazide in Combination with Telmisartan on Early Morning Blood Pressure in Uncontrolled Hypertensive Patients

Authors: Makita, Shinji; Abiko, Akihiko; Naganuma, Yujirou; Tamada, Makiko; Nakamura, Motoyuki

Source: Clinical and Experimental Hypertension, Volume 31, Number 2, April 2009 , pp. 105-115(11)

Publisher: Informa Healthcare

Combination Therapy with Candesartan Cilexetil 32 mg and Hydrochlorothiazide 25 mg Provides the Full Additive Antihypertensive Effect of the Components: A Randomized, Double-Blind, Parallel-Group Study in Primary Care

Author: Edes, Istvan

Source: Clinical Drug Investigation, Volume 29, Number 5, 2009 , pp. 293-304(12)

Publisher: Adis International

Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy

Authors: Bonner, Gerd; Group, for the Multicentre Study

Source: Blood Pressure, Volume 17, Supplement 2, December 2008 , pp. 22-30(9)

Publisher: Informa Healthcare

Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals

Author: Chrysant, Steven G.

Source: Clinical Drug Investigation, Volume 28, Number 11, 2008 , pp. 713-734(22)

Publisher: Adis International

Olmesartan Medoxomil: A Review of its Use in the Management of Hypertension

Authors: Scott, Lesley J.; McCormack, Paul L.

Source: Drugs, Volume 68, Number 9, 2008 , pp. 1239-1272(34)

Publisher: Adis International

Antihypertensive fixed combo NDA submitted in Japan.

Source: Inpharma, Volume 1, Number 1632, 2008-04-05 , pp. 26-26(1)

Publisher: Adis International

Antihypertensives/celecoxib/metformin interaction: Renal failure, lactic acidosis and pancreatitis: case report

Source: Reactions, Volume 1, Number 1198, 2008-04-19 , pp. 6-6(1)

Publisher: Adis International

Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

Author: Coca, Antonio

Source: Clinical Drug Investigation, Volume 28, Number 4, 2008 , pp. 211-220(10)

Publisher: Adis International

Valsartan/hydrochlorothiazide is effective in patients whose essential hypertension is not controlled by candesartan cilexetil and hydrochlorothiazide

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 12-12(1)

Publisher: Adis International

Systemic Hypertension and Proteinuria in Childhood Chronic Renal Parenchymal Disease: Role of Antihypertensive Drug Management

Authors: Simonetti, Giacomo D.; Santoro, Laura; Ferrarini, Alessandra; Crosazzo-Franscini, Laura; Fossali, Emilio; Bianchetti, Mario G.

Source: Pediatric Drugs, Volume 9, Number 6, 2007 , pp. 413-418(6)

Publisher: Adis International

Updated Meta-Analytical Approach to the Efficacy of Antihypertensive Drugs in Reducing Blood Pressure

Authors: Baguet, J.P.; Legallicier, B.; Auquier, P.; Robitail, S.

Source: Clinical Drug Investigation, Volume 27, Number 11, 2007 , pp. 735-753(19)

Publisher: Adis International

Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination

Authors: Schweizer, J.; Hilsmann, U.; Neumann, G.; Handrock, R.; Klebs, S.

Source: Current Medical Research and Opinion, Volume 23, Number 11, November 2007 , pp. 2877-2885(9)

Publisher: Informa Healthcare

Defining the Role of Zofenopril in the Management of Hypertension and Ischemic Heart Disorders

Author: Ambrosioni, Ettore

Source: American Journal of Cardiovascular Drugs, Volume 7, Number 1, 2007 , pp. 17-24(8)

Publisher: Adis International

Spotlight on the Pharmacoeconomics of Candesartan Cilexetil in Chronic Heart Failure and Hypertension

Authors: Plosker, Greg L.; Keam, Susan J.

Source: Disease Management & Health Outcomes, Volume 15, Number 1, 2007 , pp. 57-63(7)

Publisher: Adis International

The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects

Authors: Knauf, H.; Bailey, M.; Hasenfuss, G.; Mutschler, E.

Source: European Journal of Clinical Pharmacology, Volume 62, Number 11, November 2006 , pp. 885-892(8)

Publisher: Springer

Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension

Authors: Plosker, Greg L.; Keam, Susan J.

Source: PharmacoEconomics, Volume 24, Number 12, 2006 , pp. 1249-1272(24)

Publisher: Adis International

Aggressive antihypertensive regimens can reduce left ventricular hypertrophy and improve arterial compliance

Source: Inpharma, Volume 1, Number 1562, 2006-11-04 , pp. 18-18(1)

Publisher: Adis International

C-Reactive Protein (CRP)-Lowering Agents

Author: Prasad, Kailash

Source: Cardiovascular Drug Reviews, Volume 24, Number 1, March 2006 , pp. 33-50(18)

Publisher: Blackwell Publishing

Indapamide Sustained Release: A Review of its Use in the Treatment of Hypertension

Authors: Robinson, Dean M.; Wellington, Keri

Source: Drugs, Volume 66, Number 2, 2006 , pp. 257-271(15)

Publisher: Adis International